Boosting Infection Protection In Myeloma Patients With Ivig Therapy Betsy Odonnell Md
3:45
183
Boosting Infection Protection In Myeloma Patients With Ivig Therapy Betsy Odonne
Combination Of Isatuximab Carfilzomib Lenalidomide Dex In Myeloma Elizabeth Odonnell
2:32
65
Combination Of Isatuximab Carfilzomib Lenalidomide Dex In Myeloma Elizabeth Odon
Ethnicitys Impact On Myeloma Outcomes After Stem Cell Transplant Frances Cervoni Md
5:22
103
Ethnicitys Impact On Myeloma Outcomes After Stem Cell Transplant Frances Cervoni
Beating T-Cell Exhaustion The Future Of Myeloma Care Marta Chesi Erin Meermeier
6:07
254
Beating T-Cell Exhaustion The Future Of Myeloma Care Marta Chesi Erin Meermeier
New Myeloma Combinations Using Celmods And Antibody Drug Conjugates Paul Richardson Md
6:37
128
New Myeloma Combinations Using Celmods And Antibody Drug Conjugates Paul Richard
Updates From Ash-A-Palooza And Mentoring In Hematologyoncology Tax Koureslis Md
4:17
32
Updates From Ash-A-Palooza And Mentoring In Hematologyoncology Tax Koureslis Md
Teclistamab Step-Up Dosing To Prevent Crs In Relapserefractory Mm Jeffrey Matous Md
6:00
25
Teclistamab Step-Up Dosing To Prevent Crs In Relapserefractory Mm Jeffrey Matous
Bone Marrow Spatial Signatures Predict Outcomes In Rr Myeloma Patients Yoshinobu Konishi
1:54
70
Bone Marrow Spatial Signatures Predict Outcomes In Rr Myeloma Patients Yoshinobu
How Side Effect Severity Influences Patient Treatment Choice In Multiple Myeloma - Dr Hydren
17:13
189
How Side Effect Severity Influences Patient Treatment Choice In Multiple Myeloma
Frailtys Impact On Outcomes In Older Mm Patients Treated With Bispecifics Nadine Abdallah
2:44
170
Frailtys Impact On Outcomes In Older Mm Patients Treated With Bispecifics Nadine
The Current Standard Of Care In The Post-Transplant Setting Fredrik Schjesvold Md Phd Ims 2024
4:52
56
The Current Standard Of Care In The Post-Transplant Setting Fredrik Schjesvold M
Healthtree Study Dexamethasones Impact On Eye Health In Myeloma Rahul Banerjee Md Ims 2024
3:38
273
Healthtree Study Dexamethasones Impact On Eye Health In Myeloma Rahul Banerjee M
An Introduction To Healthtree For Multiple Myeloma
2:48
298
An Introduction To Healthtree For Multiple Myeloma
Setting Up Your Expectations For Having Myeloma
49:44
1.624
Setting Up Your Expectations For Having Myeloma
How Personalized Is Myeloma Treatment And How Is Changing? Introducing The Individual Risk Model
55:30
536
How Personalized Is Myeloma Treatment And How Is Changing? Introducing The Indiv
The Future Of Myeloma Drug Development Dickran Kazandjian Md
7:44
921
The Future Of Myeloma Drug Development Dickran Kazandjian Md
Mrd2Stop Can Multiple Myeloma Patients Stop Treatment? Ben Derman Md
7:47
330
Mrd2Stop Can Multiple Myeloma Patients Stop Treatment? Ben Derman Md
Overview Of Healthtree Programs For Multiple Myeloma
15:05
448
Overview Of Healthtree Programs For Multiple Myeloma
Results Of Bispecific Antibody Combination In Advanced Myeloma Yael Cohen Md Asco 2023
7:40
671
Results Of Bispecific Antibody Combination In Advanced Myeloma Yael Cohen Md Asc
Update On The Istopmm Study Sigurður Kristinsson Md Phd Ims 2024
3:13
192
Update On The Istopmm Study Sigurður Kristinsson Md Phd Ims 2024
Healthtree Podcast For Multiple Myeloma Dr Sergio Giralt Mskcc
46:06
33
Healthtree Podcast For Multiple Myeloma Dr Sergio Giralt Mskcc
Bone Marrow Spatial Signatures Predict Outcomes In Rr Myeloma Patients Yoshinobu Konishi
1:54
70
Bone Marrow Spatial Signatures Predict Outcomes In Rr Myeloma Patients Yoshinobu
Car-T Therapy Cartitude-1 Ciltacabtagene Autoleucel In Rrmm Patients Yi Lin Md Phd Asco 2023
3:27
249
Car-T Therapy Cartitude-1 Ciltacabtagene Autoleucel In Rrmm Patients Yi Lin Md P
Nutrition And The Gut Microbiome Exploring Their Role In Multiple Myeloma
1:15:58
478
Nutrition And The Gut Microbiome Exploring Their Role In Multiple Myeloma
Healthtree Podcast For Multiple Myeloma Dr Rodger Tiedemann Uhn
53:47
87
Healthtree Podcast For Multiple Myeloma Dr Rodger Tiedemann Uhn
Real Cancer Stories Janet Schurmann
4:10
588
Real Cancer Stories Janet Schurmann
Dreamm3 - Blenrep Belmaf Vs Pomdex For Relapsedrefractory Myeloma Katja Weisel Md Asco 2023
8:28
418
Dreamm3 - Blenrep Belmaf Vs Pomdex For Relapsedrefractory Myeloma Katja Weisel M
Defining High Risk Multiple Myeloma Wee Joo Chng Md Phd Ims 2024
2:30
115
Defining High Risk Multiple Myeloma Wee Joo Chng Md Phd Ims 2024
Efficacy Of Bispecifics In Black Patients In Myeloma Trials Craig Emmitt Cole Md Ims 2024
3:21
25
Efficacy Of Bispecifics In Black Patients In Myeloma Trials Craig Emmitt Cole Md